TherapeuticsMD rises on selling prescription service unit to GoodRx

TherapeuticsMD

07/03/2022 13:19

** Shares of women's healthcare co  TXMD.O  jump 52.4% to
$0.32 premarket - on track to hit highest level in over two
months if gains hold 
    ** Shares of online prescription drug platform  GDRX.O  fall
4% to $15.34 premarket 
    ** GDRX agreed to acquire TXMD's prescription service unit,
vitaCare, for $150 mln in cash  urn:newsml:reuters.com:*:nBw6J5JPta
    ** Deal includes additional $7 mln payment based on
vitaCare's 2023 financial performance 
    ** GDRX says it expects unit to contribute less than 1% to
revenue, reduce adj. EBITDA margin by about 2% in 2022
    ** Under deal, TXMD will also enter into services agreement
with vitaCare 
    ** Up to Friday's close, TXMD down 40.9% and GDRX down 51.1%
YTD 

 (Reporting by Bhanvi Satija in Bengaluru)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))